Jeff Knight
Geschäftsführer bei CRINETICS PHARMACEUTICALS, INC.
Vermögen: 2 Mio $ am 30.04.2024
Profil
Jeff E Knight is currently the Chief Operating Officer at Crinetics Pharmaceuticals, Inc. He previously worked as the Executive Director-Global Development Operations at Amgen, Inc. from 2015 to 2017, as the VP-Clinical Operations & Project Management at Onyx Pharmaceuticals, Inc. from 2012 to 2015, as the VP-Development Operations & Portfolio Management at Halozyme Therapeutics, Inc. from 2017 to 2018, and as the SVP-Portfolio Management & Corporate Operations at Poseida Therapeutics, Inc. from 2018 to 2021.
Mr. Knight received his undergraduate degree from the University of Kansas and his graduate degree from the University of Oklahoma.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.04.2024 | 52 580 ( 0,07% ) | 2 Mio $ | 30.04.2024 |
Aktive Positionen von Jeff Knight
| Unternehmen | Position | Beginn |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Geschäftsführer | 30.08.2021 |
Ehemalige bekannte Positionen von Jeff Knight
| Unternehmen | Position | Ende |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Corporate Officer/Principal | 31.08.2021 |
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | 01.10.2018 |
| AMGEN INC. | Corporate Officer/Principal | 01.03.2017 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01.07.2015 |
Ausbildung von Jeff Knight
| University of Kansas | Undergraduate Degree |
| University of Oklahoma | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| POSEIDA THERAPEUTICS, INC. | Health Technology |
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
